We're Moving to
The content you are trying to access has moved to new site. Explore, discover (and in certain contries, buy) our products and services on our new website. Click to visit now or you will be automatically redirected.
to view non-migrated solutions
The European ScreeningPort (ESP) enables academic researchers with promising data on the causes of disease to get physiologically relevant results and help support translating them into potential new therapeutics.
The platform harnesses a novel patented optical imaging technology to facilitate non-invasive longitudinal monitoring of disease progression, cell trafficking and gene expression patterns in living animals.
Get new insights from your assays that you could not achieve before with the first benchtop system with well-imaging alongside label-free and labeled detection.
All-in-one-well multiplexing reagent technology that provides highly sensitive detection of a wide range of analytes in a simple no-wash assay format
监测疾病发展的过程，对于更好地理解药物设计、安全和功效至关重要。
我们的解决方案聚焦于靶标发现、阳性到先导化合物优化，以及方法开发和筛选，让科学家尽早确定候选药物的有效性。从创新型的活体和体外检测方法到靶标发现、高通量筛选、先导化合物优化和临床前试验解决方案，科学家可通过系统的科学研究作出更好的决策，更经济有效地预测药物研发进程。